Search Result for 'Lymphoma'

HIV-1 infection Voclosporin (Lupkynis) Aurinia Calcineurin inhibitor Lupus nephritis Tepotinib (Tepmetko) EMD Serono MET kinase inhibitor NSCLC Umbralisib (Ukoniq) TG ...

urinary tract infections who have limited or no alternative treatment options Press Release Drug Trials Snapshot 36. Brukinsa zanubrutinib 11/14/2019 ...

Abstract Alectinib (ALB) is a kinase inhibitor typically used for patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer. ...

major form of lung carcinoma that persists. Brigatinib (BGT), a powerful small-molecule tyrosine kinase inhibitor, has demonstrated significant therapeutic potential ...

emphasizing the critical need for the advancement of novel therapeutic approaches. Key players in the regulation of apoptosis, a fundamental ...

Sarcoma: Starts in the surrounding and supporting tissue e.g. bones, cartilage, fat, muscle or blood vessels. Leiomyosarcoma, liposarcoma, and osteosarcoma ...

of biological products have been approved for prevention of diseases (e.g., vaccines), for treatment of autoimmune diseases (e.g., arthritis, psoriasis), ...

worldwide in 2020, which corresponds to approximately 20 % of all cancer-related mortality . Oncogenic driver mutations in genes such ...

PROTAC, MS4078, were developed and evaluated in terms of their feasibility for this modality. (7) MS4078 (structure see Figure S1) ...

(ALL). And in October, the FDA approved the second CAR-T cell therapy — Yescarta (axicabtagene ciloleucel) — for treating adult ...